ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

In Brief: Two Major Appointments Made At Fox Chase; HHS Names Task Force to Look At DRG Research Impact

April 20, 1984

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980